Over the last 7 days, the Pharma industry has risen 1.7%, driven by gains in Merck and Eli Lilly of 3.9% and 1.5%, respectively. In the last 12 months, the industry was up 19%. Looking forward, earnings are forecast to grow by 28% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 26 Jun 2024 | US$2.0t | US$357.6b | US$14.0b | 15.9x | 140.6x | 5.5x |
Fri, 24 May 2024 | US$1.9t | US$358.3b | US$14.1b | 17.8x | 135.5x | 5.3x |
Sun, 21 Apr 2024 | US$1.8t | US$357.7b | US$29.8b | 20.6x | 59.9x | 5x |
Tue, 19 Mar 2024 | US$1.9t | US$355.4b | US$22.5b | 19.6x | 83.3x | 5.3x |
Thu, 15 Feb 2024 | US$1.8t | US$354.9b | US$22.8b | 32.7x | 80.8x | 5.2x |
Sat, 13 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 26.3x | 52.6x | 4.7x |
Mon, 11 Dec 2023 | US$1.7t | US$375.1b | US$33.9b | 26.6x | 48.9x | 4.4x |
Wed, 08 Nov 2023 | US$1.7t | US$376.9b | US$33.9b | 19.2x | 48.9x | 4.4x |
Fri, 06 Oct 2023 | US$1.7t | US$381.8b | US$43.8b | 19.5x | 37.7x | 4.3x |
Sun, 03 Sep 2023 | US$1.7t | US$381.4b | US$43.7b | 19.6x | 39.7x | 4.5x |
Tue, 01 Aug 2023 | US$1.7t | US$393.7b | US$61.5b | 18.7x | 27.7x | 4.3x |
Thu, 29 Jun 2023 | US$1.7t | US$392.8b | US$60.1b | 18.9x | 28.8x | 4.4x |
Sat, 27 May 2023 | US$1.7t | US$392.9b | US$60.6b | 17.8x | 27.6x | 4.3x |
Mon, 24 Apr 2023 | US$1.7t | US$402.6b | US$63.3b | 17.8x | 26.3x | 4.1x |
Wed, 22 Mar 2023 | US$1.6t | US$401.1b | US$69.3b | 15.6x | 22.5x | 3.9x |
Fri, 17 Feb 2023 | US$1.6t | US$401.8b | US$68.8b | 18.6x | 23.5x | 4x |
Sun, 15 Jan 2023 | US$1.7t | US$403.7b | US$70.6b | 17.6x | 24.6x | 4.3x |
Tue, 13 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 17x | 25.1x | 4.4x |
Thu, 10 Nov 2022 | US$1.7t | US$403.5b | US$71.1b | 12.6x | 23.9x | 4.2x |
Sat, 08 Oct 2022 | US$1.5t | US$403.0b | US$71.3b | 12.2x | 21.7x | 3.8x |
Mon, 05 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 14.6x | 21.8x | 3.9x |
Wed, 03 Aug 2022 | US$1.6t | US$405.2b | US$69.7b | 21x | 23.6x | 4.1x |
Fri, 01 Jul 2022 | US$1.7t | US$392.6b | US$65.1b | 22.1x | 25.9x | 4.3x |
Sun, 29 May 2022 | US$1.7t | US$392.5b | US$64.8b | 22x | 26.4x | 4.4x |
Tue, 26 Apr 2022 | US$1.6t | US$374.7b | US$59.8b | 22.3x | 27.4x | 4.4x |
Thu, 24 Mar 2022 | US$1.6t | US$373.7b | US$60.3b | 21x | 27x | 4.4x |
Sat, 19 Feb 2022 | US$1.5t | US$373.4b | US$59.2b | 21.1x | 25.7x | 4.1x |
Mon, 17 Jan 2022 | US$1.6t | US$361.3b | US$37.7b | 24.3x | 42.4x | 4.4x |
Wed, 15 Dec 2021 | US$1.6t | US$361.1b | US$38.1b | 22x | 41.4x | 4.4x |
Fri, 12 Nov 2021 | US$1.6t | US$360.5b | US$38.3b | 21.6x | 41.7x | 4.4x |
Sun, 10 Oct 2021 | US$1.5t | US$337.7b | US$24.8b | 19.4x | 60.2x | 4.4x |
Tue, 07 Sep 2021 | US$1.6t | US$338.7b | US$25.4b | 17.8x | 62.1x | 4.6x |
Thu, 05 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 20.5x | 61.2x | 4.7x |
73.2x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -0.27% | |
Healthcare | 0.76% | |
Pharma | 1.71% | |
Pharma | 1.71% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
MRK Merck | US$132.92 | 3.9% +US$12.5b | 17.3% | PE146x | |
LLY Eli Lilly | US$904.61 | 1.5% +US$11.8b | 94.7% | PE132.7x | |
JNJ Johnson & Johnson | US$147.19 | 1.1% +US$3.7b | -9.9% | PE20.7x | |
PFE Pfizer | US$27.99 | 2.1% +US$3.3b | -23.1% | PS2.9x | |
BMY Bristol-Myers Squibb | US$42.19 | 3.4% +US$2.8b | -34.8% | PS1.9x |